Pancreatic cancer screening follow-up for high-risk people
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study checks people who are at higher risk for pancreatic cancer using an ultrasound camera passed into the digestive tract (endoscopic ultrasound, EUS), then tracks their results over time. It may help catch early signs and better understand how screening works for high-risk groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 80, and you must be able to join at the study hospital or related research centers
- You must fit at least one high-risk category for pancreatic cancer
- You must be willing to take part and sign informed consent
- You need to be medically able to safely undergo an endoscopic exam (EUS)
- You and/or your family must understand the study goals well enough to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study looks at how to screen the pancreas in people who are at increased risk for pancreatic cancer, using a set of risk guidelines. Screening may help find cancer (or early changes) sooner, when it may be easier to treat.
This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.
This study will see if people over 50 with new-onset diabetes can benefit from imaging scans (CT or endoscopic ultrasound) to help catch pancreatic ductal adenocarcinoma at an early stage. The goal is to screen those who might be at higher risk based on the END-PDAC score.
This study offers regular pancreas screening (like imaging or blood tests) to people who have a higher risk of developing pancreatic cancer. It aims to catch any early signs of cancer in those with certain family histories, genetic mutations, or other risk factors, potentially leading to earlier treatment.
Hear when a new Carcinoma, Pancreatic Ductal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.